Japan Health Insurance to Cover Cancer Therapy Gene Screening
Newsfrom JapanSociety Lifestyle
Tokyo, May 29 (Jiji Press)--Japan's Central Social Insurance Medical Council on Wednesday approved the coverage of new genetic screening for genome-based cancer treatment by the public medical insurance program, effective from Saturday.
The price was set at 560,000 yen per round of screening. Under the universal insurance program, patients will pay 10 to 30 pct of the cost out of their pockets in principle.
In currently available tests, only a small number of genes can be examined. The newly approved screening will enable the detection of 100 mutations at once.
The screening results will be utilized to help select cancer drugs suitable for each patient.
Chugai Pharmaceutical Co. <4519> and Sysmex Corp. <6869> had applied for public medical insurance coverage of their new genetic screening systems.
[Copyright The Jiji Press, Ltd.]